Kate Haviland's Net Worth
$21.5 Million
Who is Kate Haviland?
Kate Haviland has an estimated net worth of $21.5 Million. This is based on reported shares across multiple companies, which include Fulcrum Therapeutics, Inc., and Blueprint Medicines Corp.
SEC CIK
Kate Haviland's CIK is 0001663022
Past Insider Trading and Trends
2019 was Kate Haviland's most active year for acquiring shares with 9 total transactions. Kate Haviland's most active month to acquire stocks was the month of February. 2021 was Kate Haviland's most active year for disposing of shares, totalling 23 transactions. Kate Haviland's most active month to dispose stocks was the month of February. 2020 saw Kate Haviland paying a total of $748,589.15 for 81,328 shares, this is the most they've acquired in one year. In 2019 Kate Haviland cashed out on 80,515 shares for a total of $3,151,756.22, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Fulcrum Therapeutics, Inc. (FULC) Snapshot price: $8.54
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Blueprint Medicines Corp (BPMC) Snapshot price: $86.43
CHIEF EXECUTIVE OFFICER
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -7.52% | -12.46K |
$90.69 | -$1,130,360.16 | 153.18K |
Mar 7
| |||
Form 4
| +31.84% | 40K |
—
|
—
| 165.64K |
Mar 1
| |||
Form 4
| -5.02% | -6.64K |
$45.69 | -$303,353.96 | 125.64K |
Mar 6
| |||
Form 4
| +43.35% | 40K |
—
|
—
| 132.28K |
Mar 1
| |||
Form 4
| +1.21% | 1.1K |
$43.98 | $48,378.00 | 92.28K |
Nov 3
| |||
Form 4
| -2.95% | -2.77K |
$58.72 | -$162,480.77 | 91.18K |
Mar 3 - Mar 7
| |||
Form 4
| +74.15% | 40K |
—
|
—
| 93.95K |
Mar 1
| |||
Form 4
|
—
|
0
|
$67.18 | -$62,246.17 | 53.95K |
Scheduled
|
Dec 13
| ||
Form 4
|
—
|
0
|
$68.00 | -$63,885.93 | 53.95K |
Scheduled
|
Sep 13
| ||
Form 4
|
—
|
0
|
$63.15 | -$54,188.26 | 53.95K |
Scheduled
|
Jun 28
| ||
Form 4
|
—
|
0
|
$70.82 | -$69,552.62 | 53.95K |
Scheduled
|
Mar 15
| ||
Form 4
| -3.49% | -1.95K |
$86.77 | -$169,370.24 | 53.95K |
Mar 4
| |||
Form 4
| +30.49% | 13.06K |
—
|
—
| 55.9K |
Mar 1
| |||
Form 4
|
—
|
0
|
$68.16 | -$26,265.98 | 42.84K |
Scheduled
|
Nov 16
| ||
Form 4
|
—
|
0
|
$68.64 | -$869,157.07 | 42.84K |
Scheduled
|
Oct 16
| ||
Form 4
|
—
|
0
|
$50.89 | -$217,527.03 | 42.84K |
Scheduled
|
Sep 22
| ||
Form 4
| -1.54% | -671.00 |
$51.98 | -$34,878.58 | 42.84K |
Mar 9
| |||
Form 4
| +76.76% | 18.89K |
$16.28 | $75,604.32 | 43.51K |
Mar 1 - Mar 3
| |||
Form 4
|
—
|
0
|
$50.72 | -$534,715.44 | 15.87K |
Scheduled
|
Jan 10
| ||
Form 4
|
—
|
0
|
$50.64 | -$6,528.40 | 15.87K |
Scheduled
|
Aug 19
| ||
Form 4
| +170.09% | 9.99K |
$55.88 | $38,240.69 | 15.87K |
Scheduled
|
Jul 16
| ||
Form 4
|
—
|
0
|
$61.05 | -$846,274.97 | 5.87K |
Scheduled
|
Jun 17
| ||
Form 4
|
—
|
0
|
$54.09 | -$1,340,182.88 | 5.87K |
Scheduled
|
Mar 1
| ||
Form 4
|
—
|
0
|
$64.59 | -$294,437.32 | 5.87K |
Scheduled
|
Mar 16
| ||
Form 4
|
—
|
0
|
$63.03 | -$151,060.00 | 5.87K |
Scheduled
|
Mar 1
| ||
Form 4
|
—
|
0
|
$62.13 | -$166,875.70 | 5.87K |
Scheduled
|
Feb 27
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 16
| |||
Form 4
|
—
|
0
|
$45.61 | -$397,321.82 | 5.87K |
Scheduled
|
Feb 12
| ||
Form 4
|
∞
| 5.87K |
$16.28 | $95,628.72 | 5.87K |
Nov 21
| |||
Form 4
|
—
|
0
|
$41.36 | -$273,323.52 |
0
|
Scheduled
|
Oct 5
| ||
Form 4
|
—
|
0
|
$38.16 | -$278,075.00 |
0
|
Scheduled
|
Sep 18
| ||
Form 4
|
—
|
0
|
$35.47 | -$278,802.76 |
0
|
Scheduled
|
Jul 5
| ||
Form 4
|
—
|
0
|
$33.14 | -$214,358.04 |
0
|
Scheduled
|
Jun 28
| ||
Form 4/A
|
—
|
0
|
$28.15 | -$301,703.22 |
0
|
Scheduled
|
Mar 14
| ||
Form 4
|
—
|
0
|
$28.15 | -$301,703.22 |
0
|
Scheduled
|
Mar 14
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Bicara Therapeutics Inc. (BCAX) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||